Sort by
Refine Your Search
-
patented a microfluidic method for understanding platelet activity with potential to predict thrombosis risk and associated heart attack and stroke risk. These are poised for commercialisation in readiness
-
prescribing preceding lung cancer diagnosis. • Cancer risk associated with platelet counts, including the upper "high-normal" range. • Time to clinical action following elevated PSA results
-
and should have extensive experience of discrete element modelling, preferably using YADE and an understanding of clay behaviour and of recent published work on clay platelet interaction. This full-time
-
Engineering and should have extensive experience of discrete element modelling, preferably using YADE and an understanding of clay behaviour and of recent published work on clay platelet interaction. This full
-
consultations (CMV specific, irradiated, washed, fresh, HLA-matched platelets, etc.); blood component therapy; massive transfusion protocol support for trauma, obstetric and transplant patients; evaluations